FDA Adverse Event Injury Summary report: Y

SURGIWRAP® FROST

MDR report key: 24126964 · Received January 20, 2026

Report

Report Number
3004661493-2025-00001
Event Type
Injury
Date Received
January 20, 2026
Date of Event
January 24, 2023
Report Date
December 18, 2025
Manufacturer
MAST BIOSURGERY USA, INC
Product Code
FTL
PMA / PMN Number
K200918
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE REPORTED ADVERSE EVENT INVOLVED POST-OPERATIVE ILEUS REQUIRING HOSPITALIZATION FOLLOWING USE OF SURGIWRAP® FROST DURING COLORECTAL SURGERY. THE SUSPECT DEVICE WAS NOT RETURNED AND WAS THEREFORE NOT AVAILABLE FOR PHYSICAL EVALUATION. THE MANUFACTURER'S INVESTIGATION CONSISTED OF A REVIEW OF AVAILABLE CLINICAL INFORMATION AND COMPLAINT RECORDS. NO DEVICE MALFUNCTION, LABELING ISSUE, OR MANUFACTURING NONCONFORMANCE WAS IDENTIFIED. THE PHYSICIAN INDICATED THAT ALTERNATIVE CLINICAL FACTORS MAY HAVE CONTRIBUTED TO THE EVENT, AND A CAUSAL RELATIONSHIP TO THE DEVICE COULD NOT BE RULED OUT. NO REMEDIAL ACTION WAS INITIATED.

Description of Event or Problem · 0

THE PATIENT UNDERWENT ROBOTIC-ASSISTED ULTRA-LOW ANTERIOR RESECTION AND COLOSTOMY FOR RECTAL CANCER ON (B)(6) 2023, DURING WHICH SURGIWRAP FROST WAS APPLIED. POSTOPERATIVELY, THE PATIENT DEVELOPED ILEUS WITH SUBSEQUENT BOWEL OBSTRUCTION REQUIRING PROLONGED HOSPITALIZATION, IMAGING, NASOGASTRIC TUBE PLACEMENT, FASTING, FLUID INFUSION THERAPY, AND MEDICAL MANAGEMENT. THE PHYSICIAN-IN-CHARGE STATED THAT WHILE HARD STOOLS AT THE STOMA SITE WERE CONSIDERED THE MAIN CAUSE, A CAUSAL RELATIONSHIP WITH SURGIWRAP FROST COULD NOT BE COMPLETELY RULED OUT AS THE DEVICE MAY INHIBIT BOWEL MOVEMENT. THE PATIENT GRADUALLY IMPROVED WITH CONSERVATIVE TREATMENT AND NO PERMANENT IMPAIRMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
174306 SURGIWRAP® FROST BIORESORBABLE ADHESION BARRIER FILM FTL MAST BIOSURGERY USA, INC 54967

Patients

Seq Age Sex Outcome Treatment
1 66 YR Female Hospitalization| R NONE REPORTED.